Status:
RECRUITING
The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients
Lead Sponsor:
Indonesia University
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
35-59 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 pati...
Detailed Description
Subject allocation into groups will be made by third party to ensure masking/ blinding protocol. Data that will be taken from participants : * Private information * Medication history (for type 2 Di...
Eligibility Criteria
Inclusion
- Controlled Diabetes Mellitus type 2 with HbA1c \<7.5%
- BMI 23-35 kg/m2
- On anti-cholesterol therapy
Exclusion
- Using injection therapy (insulin or GLP-1 RA)
- History of bees product allergy
- Active smoker
- Consuming alcohol
- Altered liver (ALT\>35 IU/L) and kidney (eGFR\<90 mL/min) function
- Pregnant and breastfeeding women
- History of cardiovascular disease (heart attack, stroke)
Key Trial Info
Start Date :
March 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06903546
Start Date
March 18 2025
End Date
July 31 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Indonesia Faculty of Biomedical Science
Jakarta, Indonesia, 10430